Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions

Poulin, 2000, A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-bed pharmacokinetic models in drug discovery, J Pharm Sci, 89, 16, 10.1002/(SICI)1520-6017(200001)89:1<16::AID-JPS3>3.0.CO;2-E

Poulin, 2001, Prediction of adipose tissue:plasma partition coefficients for structurally unrelated drugs, J Pharm Sci, 90, 436, 10.1002/1520-6017(200104)90:4<436::AID-JPS1002>3.0.CO;2-P

Poulin, 2002, Prediction of pharmacokinetics prior to in vivo studies. I. Mechanism-based prediction of volume of distribution, J Pharm Sci, 91, 129, 10.1002/jps.10005

Poulin, 1995, A biologically based algorithm for prediction human tissue:blood partition coefficients of organic chemicals, Hum Exp Toxicol, 14, 273, 10.1177/096032719501400307

Poulin, 1995, An algorithm for prediction human tissue:blood partition coefficients of organic chemicals from n-octanol:water partition coefficient data, J Toxicol Environ Health, 46, 101, 10.1080/15287399509532021

Rodgers, 2005, Tissue distribution of basic drugs: accounting for enantiomeric, compound and regional differences amongst β-blocking drugs in rats, J Pharm Sci, 94, 1237, 10.1002/jps.20323

Rodgers, 2005, Physiologically-based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases, J Pharm Sci, 94, 1259, 10.1002/jps.20322

Bree, 1989, Binding to alpha 1-acid glycoprotein and relevant apparent volume of distribution, Progress in Clin Biol Res, 300, 321

1992, Applied pharmacokinetics, principles of therapeutic drug monitoring

Chen, 2004, Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography, J Chromatogr B, 809, 137, 10.1016/j.jchromb.2004.06.012

Aubry, 1995, Comparison of drug binding interactions on human, rat and rabbit serum albumin using high-performance displacement chromatography, Comp Biochem Physiol, 112C, 257

Rahman, 1993, Studies of interaction of caprofen and its enantiomers with albumin I: mechanism of binding studied by dialysis and spectroscopic methods, Biochem Pharmacol, 46, 1721, 10.1016/0006-2952(93)90576-I

1982, Phospholipids, 2p

Nelson, 1967, The phospholipids composition of plasma in various mammalian species, Lipids, 2, 323, 10.1007/BF02532119

Kawai, 1994, Physiologically based pharmacokinetic study on a cyclosporine derivative, SDZ IMM 125, J Pharmacokin Biopharm, 22, 327, 10.1007/BF02353860

Ballard, 2003, Prediction of in vivo tissue distribution from in vitro data. 3. Correlation between in vitro and in vivo tissue distribution of a homologous series of nine 5-n-alkyl-5-ethyl barbituric acids, Pharm Res, 20, 864, 10.1023/A:1023912318133

Berezhkovskiy, 2004, Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination, J Pharm Sci, 93, 1628, 10.1002/jps.20073

Bjorkman, 1990, Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats, Anaesthesiology, 72, 865, 10.1097/00000542-199005000-00017

Gueorguieva, 2004, Development of a whole body physiologically based model to characterise the pharmacokinetics of benzodiazepines 1: estimation of rat tissue-plasma partition coefficients, J Pharmacokin Pharmacodyn, 31, 269, 10.1023/B:JOPA.0000042737.14033.c6

Igari, 1983, Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model, J Pharmacokin Biopharm, 11, 577, 10.1007/BF01059058

Bjorkman, 1996, Determination of the steady state distribution of midazolam in the rat, J Pharm Sci, 85, 887, 10.1021/js960113+

Tsuji, 1983, Physiologically based pharmacokinetic model for β-lactam antibiotics I: tissue distribution and elimination in rats, J Pharm Sci, 72, 1239, 10.1002/jps.2600721103

Yamazaki, 2004, Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds, J Pharm Sci, 93, 1480, 10.1002/jps.20059

Lee, 1988, Kinetics and mechanisms of etodolac degradation in aqueous solutions, J Pharm Sci, 77, 81, 10.1002/jps.2600770116

Brooks, 1990, The pharmacokinetics of etodolac enantiomers in the rat: lack of pharmacokinetic interaction between enantiomers, Drug Metab Dispos, 18, 471

Sawada, 1985, Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats, J Pharmacokin Biopharm, 13, 477, 10.1007/BF01059331

Zhao, 2002, High-throughput LogP measurement using parallel Liquid chromatography/ultraviolet/mass spectrometry and sample pooling, Rapid Commum Mass Spectrom, 16, 1548, 10.1002/rcm.749

Chatton, 1990, Salictclic acid permeability properties of the rabbit cortical collecting duct, Am J Physiol, 259, F613

Yoshikawa, 1984, Effect of pregnancy on tissue distribution of salicylate in rats, J Pharm Sci, 12, 500

Guntert, 1986, Acceleration of the elimination of tenoxicam by cholestyramine in the dog, J Pharmacol Exp Ther, 238, 295

Kwon, 1987, Physiological pharmacokinetic model for the distribution and elimination of tenoxicam, Int J Pharmaceut, 37, 219, 10.1016/0378-5173(87)90032-9

Worboys, 1997, Kinetics of metabolism in rat liver slices III. Relationship between metabolic clearance and slice uptake, Drug Metab Dispos, 25, 460

Kessel, 2001, Continuum solvent model studies of the interactions of an anticonvulsant drug with a lipid bilayer, Biophys J, 80, 2536, 10.1016/S0006-3495(01)76225-X

Tanaka, 2000, Dose-dependant pharmacokinetics of cyclosporine A in rats: events in tissues, Drug Metab Dispos, 28, 582

Poulin, 2002, Prediction of pharmacokinetics prior to in vivo studies.II. Generic physiologically based pharmacokinetic models of drug disposition, J Pharm Sci, 91, 1358, 10.1002/jps.10128

Sakiya, 1985, Prediction of ftorafur disposition in rats and man by a physiologically based pharmacokinetic model, Int J Pharm, 25, 347, 10.1016/0378-5173(85)90174-7

Okezaki, 1988, Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids, Drug Metab Dispos, 16, 865

Naber, 2003, Antibiotic therapy-rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue, Andrologia, 35, 331, 10.1111/j.1439-0272.2003.tb00868.x

Martin, 1993

Davies, 1993, Physiological parameters in laboratory animals and humans, Pharm Res, 10, 1093, 10.1023/A:1018943613122

1995, Clinical pharmacokinetics: Concepts and applications, 502

Bjorkman, 2002, Prediction of the volume of distribution of a drug: which tissue-plasma partition coefficients are needed?, J Pharm Pharmacol, 54, 1237, 10.1211/002235702320402080

Tsuji, 1989, Age-related change in tissue-to-plasma partition coefficient of cefazolin for noneliminating organs in the rat, J Pharm Sci, 78, 535, 10.1002/jps.2600780705

Kang, 1997, Physiologically based pharmacokinetic models of 2′, 3′-dideoxyinosine, Pharm Res, 14, 337, 10.1023/A:1012002206007

Brooks, 1991, Enantioselective pharmacokinetics of etodolac in the rat: tissue distribution, tissue binding and in vitro metabolism, J Pharm Sci, 80, 1058, 10.1002/jps.2600801112

Yoshikawa, 1984, Effect of pregnancy on tissue distribution of salicylate in rats, Drug Metab Dispos, 12, 500

Ebling, 1994, From piecewise to full physiologic pharmacokinetic modelling: applied to thiopental disposition, J Pharmacokin Biopharm, 22, 252, 10.1007/BF02353622

Harrison, 1977, Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat, J Pharm Sci, 66, 1138, 10.1002/jps.2600660822

Funakoshi, 2005, Role of organic anion transporting polypeptide 2 in pharmacokinetics of digoxin and -methyldigoxin in rats, J Pharm Sci, 94, 1196, 10.1002/jps.20346

Lin, 1982, In vitro and In vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic models, J Pharmacokin Biopharm, 10, 637, 10.1007/BF01062545

Granero, 1998, Distribution of ceftazidime in rat tissues, Biopharm Drug Dispos, 19, 473, 10.1002/(SICI)1099-081X(199810)19:7<473::AID-BDD125>3.0.CO;2-M

Olanoff, 1979, Controlled release of tetracycline II: development of an in vivo flow-limited pharmacokinetic model, J Pharm Sci, 68, 1151, 10.1002/jps.2600680925

1995, Clinical pharmacokinetics: Concepts and applications, 149

Ooie, 1997, Quantitiaive brain microdialysis study on the mechanism of quinolones distribution in the central nervous system, Drug Metab Dispos, 25, 784

Takasawa, 1997, Distributed model analysis of 3′-Azido-3′-deoxythymidine and 2′,3′-dideoxyinosine distribution in brain tissue and cerebrospinal fluid, J Pharmacol Exp Ther, 282, 1509

Yu, 1995, Analysis of tissue distribution of valproate in guinea-pigs: evidence for its capacity limited distribution, Pharm Res, 12, 421, 10.1023/A:1016264821127

Jusko, 1976, Plasma and tissue protein binding of drugs in pharmacokinetics, Drug Metab Rev, 5, 43, 10.3109/03602537608995839

Kullak-Ublick, 1999, Regulation of organic anion and drug transporters of the sinusoidal membrane, J Hepatol, 31, 563, 10.1016/S0168-8278(99)80054-3

Ayrton, 2001, Role of transport proteins in drug absorption, distribution and excretion, Xenobiotic, 31, 469, 10.1080/00498250110060969

Olanoff, 1980, Controlled release of tetracycline III: a physiological pharmacokinetic model of the pregnant rat, J Pharmacokin Biopharm, 8, 599, 10.1007/BF01060056

Funakoshi, 2003, Role of P-glycoprotein in pharmacokinetics and drug interactions of digoxin and -methyldigoxin in rats, J Pharm Sci, 92, 1455, 10.1002/jps.10416

Fichtl, 1991, Tissue binding versus plasma binding of drugs: general principles and pharmacokinetic consequences, Adv Drug Res, 20, 117, 10.1016/B978-0-12-013320-8.50006-X

Schuhman, 1987, Prediction of drug distribution in vivo on the basis of in vitro binding data, Biopharm Drug Dispos, 8, 73, 10.1002/bdd.2510080109

Pierson, 1978, Extracellular water measurements: organ tracer kinetics of bromide and sucrose in rats and man, Am J Physiol, 235, F254